Abstract: A method and apparatus decode packetized data in the presence of packet erasures using a finite sliding window technique. A decoder receives packets containing uncoded and coded symbols. When a packet with a coded symbol is received, the decoder determines whether a packet sequence number is within a sliding window of w consecutive sequence numbers that are no greater than a decoder sequence number, where the number w is fixed prior to encoding. When this is the case, the decoder decodes the coded symbol into one or more of the w input symbols using the coefficient vector. Decoding may use a forward error correcting (FEC) window within the finite sliding window. Decoding also may use a technique of Gaussian elimination to produce a “shifted” row echelon coefficient matrix.

Abstract: An extrusion additive manufacturing process including the step of extruding a polyethylene composition having a melt flow index MIE of at least 0.1 g/10 min., the composition made from or containing: A) from 1% to 40% by weight of a polyethylene component having a weight average molar mass Mw, as measured by GPC (Gel Permeation Chromatography), equal to or higher than 1,000,000 g/mol; B) from 1% to 95% by weight of a polyethylene component having a Mw value from 50,000 to 500,000 g/mol; and C) from 1% to 59% by weight of a polyethylene component having a Mw value equal to or lower than 5,000 g/mol.

Abstract: The present invention relates to the use of a combination of plant extracts from the genera Salvia, Artemisia, Echinacea, and optionally further plant extracts, for the cosmetic treatment of the skin. The invention further relates to cosmetic preparations which comprise such combination of plant extracts. These plant extracts and cosmetic preparations are particularly useful for stimulation of the lymphatic system, including rejuvenation, anti-ageing, detoxification and increased firmness of the skin, for puffy-eye treatment and/or for anti-swelling effects.

Abstract: The present description relates to a method and a device for providing anyons that may be used for topological quantum computation. The method comprises the steps of providing a magnetic material containing at least one magnetic texture providing a superconductor containing at least one vortex; creating at least one magnetic texture-vortex pair by coupling the magnetic material to the superconductor, wherein each magnetic texture-vortex pair binds an anyon being localized at the vortex of the respective magnetic texture-vortex pair in the superconductor.

Abstract: The present invention relates to a method for monitoring a vehicle convoy containing at least two vehicles (1.1, 1.2), wherein the at least two vehicles (1.1, 1.2) in the vehicle convoy are each formed with a communication system, which is configured to use vehicle-to-vehicle communication to send and/or receive information, and a measuring apparatus, which is configured to capture values for at least one kinematic state parameter. The method involves kinematic state parameters being ascertained and regulated for at least one pair of vehicles (1.1, 1.2) in the vehicle convoy, which pair is formed by a first vehicle (1.1) in the vehicle convoy and a second vehicle (1.2) in the vehicle convoy arranged directly after the first vehicle (1.1) in the vehicle convoy, by means of allocated time and frequency resources.

Abstract: At least one substrate part for is provided for coating. A first deposition is provided on the at least one support part as microstructuring of at least one first substance selected from the group consisting of rhenium, ruthenium, rhodium, palladium, silver, osmium, iridium, platinum, gold, tin, zinc, copper, cobalt, lead, nickel and alloys comprising these, from at least one first compound which provides the at least one first substance. A second deposition is provided on the at least one support part as a nano-structuring of at least one second substance chosen from a group comprising rhenium, ruthenium, rhodium, palladium, silver, osmium, iridium, platinum, gold and/or alloys thereof, of at least one second compound which provides the at least one second substance, in a solution.

Abstract: The present invention provides a pharmaceutical composition for use in prevention or treatment of a human rhinovirus (HRV) infection. The composition comprises an aldohexose, wherein the hydroxyl group at carbon 2 of the aldohexose is replaced by any one of H, F, Cl, Br, I, SH, Me, OMe and SMe, such as a 2-deoxy-glucose. Furthermore, a dispenser for intranasal administration, such as a nasal spray or nose drop applicator containing said pharmaceutical composition is provided. In addition, an inhalation device, such as a metered-dose inhaler, a dry-powder inhaler or a nebuliser, comprising said composition is provided.

Abstract: The present invention relates to a ligand-SIFA-chelator conjugate, comprising, within in a single molecule three separate moieties: (a) one or more ligands which are capable of binding to a disease-relevant target molecule, (b) a silicon-fluoride acceptor (SIFA) moiety which comprises a covalent bond between a silicon atom and a fluorine atom, and (c) one or more chelating groups, optionally containing a chelated nonradioactive or radioactive cation.

Abstract: The invention relates to a method and a computer program for estimating a bilirubin level of a neonate, comprising the steps of: Acquiring a series of bilirubin levels estimated at different time points from a sample obtained from a neonate, Acquiring a plurality of covariates from the neonate, each comprising an information about a neonatal property, Providing a pre-defined bilirubin model function, wherein the bilirubin model function is configured to describe a time course of a bilirubin level of a neonate, —Determining a plurality of model parameters of the bilirubin model function, wherein each model parameter is estimated from at least one covariate of the plurality of covariates and an associated population model parameter, Determining from the series of acquired bilirubin levels and the bilirubin model function with the determined model parameters an expected bilirubin level of the neonate for a time particularly later than a lastly acquired bilirubin level of the series of bilirubin levels.

Abstract: The person invention relates to a method for the electro-decarboxy lation of at least one diene with carbon dioxide CO2 in the presence of hydrogen H2, forming at least one unsaturated dicarboxylic acid, wherein the reaction is carried out in a reactor comprising at least one cathode as the working electrode for the cathodic activation of CO2, at least one anode as the counter-electrode for the anodic oxidation of H2, with a volumetric ration of hydrogen H2 to carbon dioxide CO2 between 1:1 and 1:3, a total pressure pg in the reactor between 2 and 4 MPa, particularly preferably between 3 and 4 MPa, and an average current density j between 5 and 15 mA/cm2, particularly preferably between 10 and 12.5 mA/cm2.

Abstract: A self-powered system and a method for power extraction and measurement of energy-generator units are disclosed. The system comprises an energy generator unit (10) providing an electrical current IFC and a voltage VFC; an instrumentation block (20) to measure the electrical current IFC; and a power management unit (30) connected to the energy generator unit (10) via a first input that collects the electrical current IFC, extracting an electrical power provided by the energy generator unit (10). The power management unit (30) also has a second input which is connected to a feedback element (40) connected to a voltage reference VREF, to the voltage VFC and to the instrumentation block (20). A variation of an equivalent input impedance of the power management unit (30) sets a given parameter of the energy generator unit (10) to a controlled given value and the instrumentation block (20) assists in the control of the parameter.

Abstract: Compounds of general Formula (I) wherein the elements A, L, R1 and R2 have a defined meaning, and their medical and non-medical use. The compounds may be used treatment of a subject in need of any one or more of anti-inflammatory, anti-oxidative, anti-ageing, or lipid metabolism modulation therapy or prophylaxis. The compounds may also be used as food or feed products, dietary supplements or cosmetic preparations.

Abstract: The present disclosure provides methods and composition including vaccines, monoclonal antibodies, polyclonal antibodies, chimeric molecule of an extracellular fibrinogen binding protein (Efb) and targeted agent delivery pharmaceutical composition comprising at least a portion of a modified N-terminus region, at least a portion of a modified C-terminus region, or both, wherein the modified extracellular fibrinogen binding protein results in inhibiting the fibrinogen binding, C3 binding, or both or administering to a subject a pharmacologically effective amount of a vaccine in a pharmaceutically acceptable excipient, comprising a modified extracellular fibrinogen binding protein comprising at least a portion of a modified N-terminus region, at least a portion of a modified C-terminus region, or both, wherein the modified extracellular fibrinogen binding protein results in not shielding the staphylococcus bacterium from recognition by a phagocytic receptor.

Abstract: Improvements in MR spiral imaging are provided in that spiral segments (2 to 8) are reordered, in particular alternately traversed and/or permuted. Moreover, repeatedly approaching the same post-trajectory points (16) between the acquisitions of the spiral segments (2 to 8) is provided, in which the post-trajectory points (16) are located outside of the center (18) of k-space (9), preferably outside of a region (20) of the k-space (9) covered by the spiral segments (2 to 8).

Abstract: The present invention discloses an extracellular matrix comprising a modified polysaccharide consisting of repeating disaccharide units whereby in at least 11% of the disaccharide units one primary alcohol group is oxidized into a carboxylic acid.

Abstract: An endoscope includes a shaft having a distal end, an optical imaging device at the distal end of the shaft for producing a real image of an object observed by means of the endoscope and at least one of an image transfer device for transmitting the real image and an image sensor for capturing the real image. The imaging device has curved light-refracting interfaces, which are tilted in relation to one another.

Abstract: The invention relates to nucleic acid products that interfere with PROS1 gene expression or inhibit its expression. The nucleic acids are particularly for use in the treatment, prevention or reduction of risk of suffering from a bleeding disorder.

Abstract: Method and apparatus to produce a wideband RF signal covering an increased first bandwidth, utilizing at least one narrowband transceiver (1) capable of producing an output RF signal with a base frequency fbase and a second bandwidth, wherein the second bandwidth is lower than the first bandwidth, and wherein the base frequency Case depends on the setting of at least one frequency register (2, 2?, 2?), which is adjustable by a control unit, as well as method to estimate the position of a narrowband RF transceiver (1) using a multitude of coherent wideband RF receivers (12) and computer-readable medium comprising computer-executable instructions causing an electronic device to perform the method.

Abstract: Provided is a method in a system of at least two artificial intelligence units, comprising inputting input values to at least a first artificial intelligence unit and a second artificial intelligence unit; obtaining first output values of the first artificial intelligence unit; forming one or more modulation functions based on the output values of the first artificial intelligence unit; applying the formed one or more modulation functions to one or more parameters of the second artificial intelligence unit, the one or more parameters influencing the processing of input values and the obtaining of output values in the second artificial intelligence unit; and finally obtaining second output values of the second artificial intelligence unit.

Abstract: An electrochemical method and an electrochemical sensor for breath analysis of single or multiple analytes using a porous, preferably flexible and disposable supporting material is provided, a salt is incorporated, and which can be wetted in contact with the exhaled breath condensate. The electrochemical method acting simultaneously as sampling method, as an electrolyte and as a support for the electrode structures. In some embodiments the salt may be hygroscopic, such that the porous substrate stays wet. To ensure that the obtained signal originates from the analyte, the electrochemical sensor preferably exhibits a differential electrode design, including a sensing (analyte-sensitive) and a blank (analyte-insensitive) electrode in order to isolate and remove the background signals.